| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |